Recently, we reported that aberrant loss of argininosuccinate synthetase (ASS1) caused by promoter methylation may contribute to the enhanced angiogenesis in myxofibrosarcomas [15]. The gene discussed is ASS1; the disease is myxofibrosarcoma.